*Look at the list of corrupt companies in this article!
Source: New York Times
October 22, 2010, 8:34 AM
GE Healthcare said Friday that it had agreed to buy Clarient, a molecular diagnostics firm, which it says will help the company better diagnose and characterize cancer, in a deal worth about $580 million.
John Dineen, chief executive of GE Healthcare, said the acquisition “will accelerate our expansion into cancer diagnostics and therapy selection tools,” adding that he hoped to build a diagnostics business worth more than $1 billion.
Clarient hired Goldman Sachs as financial adviser and Latham & Watkins as counsel. GE Healthcare hired JP Morgan as adviser and Sidley Austin as counsel.
So Sidley Austin raises its ugly head again. Perhaps the Bhopal plant was not enough for them and more mayhem is required. Michelle Obama (nee Robinson) will need a job when her current position is undercut by the Foreigner in the Presidency. Of course cancer is likely a man made disease with Monsanto Genetically Modified seeds written all over it (Speculation on Monsanto and cancer ,there but with reason).
ReplyDelete